GO
Loading...

Patents

More

  • U.S. jury orders Samsung to pay Apple $119.6 mln Friday, 2 May 2014 | 8:12 PM ET

    SAN JOSE, Calif., May 2- A U.S. jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, after it found the South Korean smartphone maker had infringed two Apple patents.

  • U.S. jury finds Samsung infringed two Apple patents Friday, 2 May 2014 | 8:05 PM ET

    SAN JOSE, Calif., May 2- A U.S. jury on Friday found Samsung Electronics Co Ltd has infringed two Apple Inc patents, and did not infringe two patents. The verdict is still being delivered in a San Jose, California federal courtroom.

  • Build your own portfolio with these trends     Thursday, 1 May 2014 | 12:58 PM ET

    Hardeep Walia, co-founder and CEO of Motif Investing, shares his firm's findings on the most popular trends in investing right now, including high-yield dividends.

  • *India welcomes U.S. trade decision. NEW DELHI, May 1- India said on Thursday it would hold trade talks on intellectual property rights with the United States after its general election, buying time to address friction over drug patents until a new government is formed.

  • WASHINGTON, April 30- The United States named China and India on a watch list for countries that aren't doing enough to fight intellectual-property crimes, warning of trade-secret theft in China and the proliferation of generic drugs and counterfeiting in India.

  • WASHINGTON, April 30- The United States named China and India on a watch list for countries that aren't doing enough to fight intellectual-property crimes, warning of trade-secret theft in China and the proliferation of generic drugs and counterfeiting in India.

  • SAN JOSE, Calif., April 29- Apple has vastly exaggerated the importance of its patented iPhone features, a Samsung attorney said on Tuesday as the two companies delivered closing arguments to jurors after a month-long trial over mobile technology.

  • WASHINGTON, April 25- A U.S. appeals court on Friday revived patent claims Apple made against Google's Motorola Mobility unit that had been dismissed shortly before trial, giving the iPhone maker another chance to seek a sales ban against its smartphone competitor.

  • Xilinx Inc eventually asked a California federal judge to declare those IV patents invalid, while IV countersued in Delaware, accusing Xilinx of infringement. The trial in the Xilinx case is scheduled to begin in Delaware next month.

  • WASHINGTON, April 18- U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd to stay a lower-court ruling in a patent case that favored the developers of generic versions of Teva's top-selling multiple sclerosis drug.

  • SAN FRANCISCO, April 17- A U.S. judge on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation from Google Inc's home turf in California to Texas, according to a court ruling.

  • SAN FRANCISCO, April 17- A federal judge in California on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation against Google Inc to Texas, according to a court ruling.

  • WASHINGTON, April 14- Generic drug manufacturers on Monday asked the U.S. Supreme Court to allow a lower court ruling favoring them to take effect while the high court considers an appeal in a patent fight over Teva Pharmaceutical Industries Ltd's top-selling multiple sclerosis drug, Copaxone.

  • Why Apple's the underdog in this Samsung trial Thursday, 10 Apr 2014 | 3:23 PM ET

    Apple is making some broad claims about what it owns and will have to make a strong case to prove it actually deserves as much as it is asking for.

  • MUMBAI, April 10- India's Natco Pharma Ltd has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said.

  • CNBC's Jim Cramer speaks with Robert Hugin, Celgene chairman & CEO, about America's need to build a stronger and more sustainable ecosystem of innovation to continue as the world leader in biomedical innovation.

  • Alkermes is a true drug innovator: CEO     Thursday, 10 Apr 2014 | 8:21 AM ET

    Richard Pops, chairman & CEO of Alkermes, discusses Alkermes' new injectable drug for the treatment of schizophrenia. We have more psychiatry products in our pipeline, reveals Pops.

  • Eli Lilly CEO: We keep investing in R&D     Thursday, 10 Apr 2014 | 6:51 AM ET

    John Lechleiter, Chairman, President & CEO of Eli Lilly, discusses the company's growth plans as products come off patent and consumers move to generic drugs.

  • Technology group Kudelski says Apple infringed patents Thursday, 10 Apr 2014 | 1:53 AM ET

    ZURICH, April 10- Technology group Kudelski said its OpenTV and Nagravision subsidiaries have filed a lawsuit against Apple Inc in a court in northern California alleging the iPhone maker has infringed five U.S. patents. Kudelski did not give further details about the patent suit. Apple was not immediately available for comment.

  • NXP in April 2012 sued BlackBerry, then known as Research in Motion, alleging that versions of the BlackBerry phone and PlayBook tablet infringed patents related to the design, data transmission and other features of those devices.